These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18394761)

  • 1. [C-reactive protein (CRP) after revascularized STEMI: is CRP a prognostic factor?].
    Roubille F; Cayla G; Picot MC; Pradet V; Massin F; Gervasoni R; Pasquie JL; Macia JC; Piot C; Leclercq F
    Rev Med Interne; 2008 Nov; 29(11):868-74. PubMed ID: 18394761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI.
    Roubille F; Samri A; Cornillet L; Sportouch-Dukhan C; Davy JM; Raczka F; Gervasoni R; Pasquie JL; Cung TT; Piot C; Macia JC; Cransac F; Leclercq F
    Eur J Intern Med; 2010 Apr; 21(2):131-6. PubMed ID: 20206886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
    Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
    Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
    Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
    J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction.
    Wang CH; Zhang SY; Fang Q; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ
    Am J Med Sci; 2015 May; 349(5):413-20. PubMed ID: 25782335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction.
    Makrygiannis SS; Ampartzidou OS; Zairis MN; Patsourakos NG; Pitsavos C; Tousoulis D; Prekates AA; Foussas SG; Cokkinos DV
    Am J Cardiol; 2013 Jan; 111(1):26-30. PubMed ID: 23040593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study.
    Kurt IH; Demirkol S; Ünal I; Batur MK
    Anadolu Kardiyol Derg; 2012 Mar; 12(2):107-14. PubMed ID: 22281789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
    Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.
    Reinstadler SJ; Feistritzer HJ; Klug G; Mair J; Tu AM; Kofler M; Henninger B; Franz WM; Metzler B
    Int J Cardiol; 2016 Jan; 202():188-93. PubMed ID: 26397408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
    Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
    Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
    Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
    Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
    Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction.
    Ohlmann P; Jaquemin L; Morel O; El Behlgiti R; Faure A; Michotey MO; Beranger N; Roul G; Schneider F; Bareiss P; Monassier JP
    Am Heart J; 2006 Dec; 152(6):1161-7. PubMed ID: 17161070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.
    Yip HK; Hang CL; Fang CY; Hsieh YK; Yang CH; Hung WC; Wu CJ
    Chest; 2005 Mar; 127(3):803-8. PubMed ID: 15764760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
    Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
    Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of C-reactive protein and myocardial perfusion in patients with ST-elevation acute myocardial infarction.
    Hoffmann R; Suliman H; Haager P; Christott P; Lepper W; Radke PW; Ortlepp J; Blindt R; Hanrath P; Weber C
    Atherosclerosis; 2006 May; 186(1):177-83. PubMed ID: 16140308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.
    García-García C; Subirana I; Sala J; Bruguera J; Sanz G; Valle V; Arós F; Fiol M; Molina L; Serra J; Marrugat J; Elosua R
    Am J Cardiol; 2011 Oct; 108(8):1061-7. PubMed ID: 21791326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of high sensitivity C-reactive protein with cardiac biomarkers in patients presenting with acute coronary syndrome.
    Aseri ZA; Habib SS; Alhomida AS; Khan HA
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):387-91. PubMed ID: 24953910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.